Thomas Charles Reilly

Chief Financial Officer, Tvardi Therapeutics, Inc.

Companies

Amarin CorporationChief financial officer Jul 6, 2022 to Jul 1, 2024¹
Tvardi Therapeutics, Inc.Chief financial officer Oct 7, 2020 to Mar 4, 2022²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 1, 2024Shares withheld for tax 8,209 shares at $0.69 of Amarin Corporation³
Jul 1, 2024Exercised options 16,667 shares of Amarin Corporation³
Jun 20, 2024Shares withheld for tax 16,417 shares at $0.73 of Amarin Corporation⁵
Jun 20, 2024Exercised options 33,333 shares of Amarin Corporation⁵
Jan 31, 2024Shares withheld for tax 24,552 shares at $1.24 of Amarin Corporation⁶
Jan 31, 2024Exercised options 44,933 shares of Amarin Corporation⁶
Jan 10, 2024Shares withheld for tax 28,325 shares at $0.97 of Amarin Corporation⁷
Jan 10, 2024Exercised options 51,500 shares of Amarin Corporation⁷
Jul 1, 2023Shares withheld for tax 8,209 shares at $1.19 of Amarin Corporation⁸
Jul 1, 2023Exercised options 16,667 shares of Amarin Corporation⁸
Jun 20, 2023Shares withheld for tax 16,417 shares at $1.19 of Amarin Corporation⁹
Jun 20, 2023Exercised options 33,334 shares of Amarin Corporation⁹
Mar 3, 2022Sold 2,044 shares at $11.38 of Tvardi Therapeutics, Inc.⁴
Feb 28, 2022Granted 5,333 shares at $10.29 of Tvardi Therapeutics, Inc.¹⁰
Feb 25, 2022Granted 20,000 shares of Tvardi Therapeutics, Inc.¹⁰
Dec 17, 2021Granted 11,170 shares of Tvardi Therapeutics, Inc.¹¹

The numbers on this page point here. Each one links to the record it came from.